Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00927888 · ClinicalTrials.gov registry record · Phase 4
Postoperative Pain and Functional Patient Outcomes After Functional Endoscopic Sinus Surgery
A Phase 4 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 4
- Development phase
- 56
- Enrollment target
NCT00927888: Completed Phase 4 study, sponsored by Stanford University.
NCT00927888 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00927888, a Phase 4 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 56 participants
- Enrollment target
Study Summary
The aim of the study is to quantify postoperative pain after functional endoscopic sinus surgery (FESS) and investigate whether preemptive analgesia may positively impact intraoperative anesthetic management, decrease patient postoperative pain and discomfort, and improve patient functional outcomes.
Interventions
- DRUG Placebo
- DRUG Bupivacaine Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2007-08 |
| Est. Completion | 2010-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00927888
The ClinicalTrials.gov registry entry for NCT00927888 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00927888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00927888 about?
NCT00927888 is a clinical study titled "Postoperative Pain and Functional Patient Outcomes After Functional Endoscopic Sinus Surgery". The aim of the study is to quantify postoperative pain after functional endoscopic sinus surgery (FESS) and investigate whether preemptive analgesia may positively impact intraoperative anesthetic management, decrease patient postoperative pain and discomfort, and improve patient functional outcomes...
What is the current status of trial NCT00927888?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 56 participants. The study started on 2007-08. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00927888?
The interventions under investigation include: Placebo (DRUG), Bupivacaine Block (DRUG).
Who is sponsoring clinical trial NCT00927888?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.